Locally instilled tumor necrosis factor-α antisense oligonucleotide inhibits allergic inflammation via the induction of Tregs.

Yi Luo,Zhonghua Pang,Qian Zhu,Xing Cai,Yuan Yin,Min Wang,Jie Zhu,Jiangning Chen,Ke Zeng,Chenyu Zhang,Junfeng Zhang

DOI: https://doi.org/10.1002/jgm.2631

2012-01-01

Abstract:Background Anti-tumor necrosis factor (TNF)-a therapeutics has the potential to alleviate allergic inflammation. However, in previous studies, the systemic administration of anti-TNF-a agents was frequently accompanied by many adverse effects, such as infection, immunogenicity and malignancy. Efforts are made in the present study to evaluate whether or not local administration of TNF-a antisense oligonucleotide would inhibit allergic airway inflammation and influence systemic immune responses in an ovalbumin-induced asthmatic murine model. Methods The treatment effects of TNF-a antisense oligonucleotide on mice, as well as the alternative proportion of regulatory T cells and TH2 cells, were examined and compared with untreated mice. Results Local administration of TNF-a antisense oligonucleotide resulted in significantly inhibited TNF-a expression, remarkably decreased inflammatory cell infiltration and dramatically reduced mucus hypersecretion. These treatment effects were associated with induced CD4+CD25+Foxp3+ regulatory T cells, reduced TH2 cells and generally decreased TH2-type cytokines expression in bronchoalveolar lavage fluid. Systemic immunosuppression was not triggered by local antisense oligonucleotide administration because the proportion of CD4+CD25+Foxp3+ regulatory T cells in the blood, thymus or spleen was not affected. Attenuated 4-1BBL expression was likely involved in the alternative proportion of T cells. Conclusions These findings demonstrate that local administration of TNF-a antisense oligonucleotide contributes to anti-inflammatory action via the enhancement of regulatory T cells-mediated immune tolerance, which is not accompanied by systemic immunosuppression associated with systemically-induced regulatory T cells. Copyright (c) 2012 John Wiley & Sons, Ltd.